Date:  09/15/2009

Time:   9:00 am – 12:00 pm

Location:   Citizen Hotel Sacramento, California

Speaker:   Christopher Russell

Description:  

TechCoire and Morrison & Foerster LLP are proud to partner together to present this hands-on workshop on securing grants and tapping into the stimulus bill for your cleantech and life science business.

Applying for and receiving grants from the federal government is neither a quick or easy process. However, these monies are one of the most important sources of funds for the development of high risk-high reward technology. This seminar will go through structuring your company mindset for the federal grant writing process, discussion of some specific federal programs, and review the nuts and bolts of submitting a grant application. Following that, there’ll be specific discussion on the size and scope of the economic stimulus package as it related to clean technology companies as well as specific industry sectors that will be benefiting from funds that are being made available.

If you are seeking grants for your life science or cleantech businesses, you cannot afford to ignore this event. Visit www.techcoire.com to learn more and to register for this limited seating workshop.

Registration
Non-Members: $150, Members: $75, before August 15, 2009.

About the Speakers

Rich Giersch is the Director of Grants with 21 Ventures, a VC firm based in New York and is an experienced grant developer and biotechnology executive. In his role as Grants Director, he works with 21 Ventures portfolio companies to help identify, write, and administer grants and other forms of non-dilutive funds.

Chris Russell, Of Counsel, Morrison & Foerster LLP

Chris Russell's practice focuses on corporate and securities matters, mergers and acquisitions, venture capital and corporate financings, formation of limited liability companies, venture capital funds and other investment partnerships, corporate restructurings, federal and state securities law compliance, and general corporate and securities counseling of public and private companies.